SCHEMBL15699019

SCHEMBL15699019

Cc1ccc(Nc2cccc3c2oc2ccccc23)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.53
ALDH1A1 P00352 6/20 0.53
MAPT P10636 6/20 0.53
HPGD P15428 6/20 0.53
SMN1; SMN2 Q16637 5/20 0.53
NPC1 O15118 4/20 0.53
RAB9A P51151 4/20 0.53
CASP3 P42574 1/20 0.53
SENP7 Q9BQF6 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
GAA P10253 5/20 0.49
LMNA P02545 5/20 0.49
HTT P42858 3/20 0.49
TDP1 Q9NUW8 2/20 0.47
KMT2A Q03164 8/20 0.42
MEN1 O00255 6/20 0.42
GLA P06280 1/20 0.42
RECQL P46063 1/20 0.42
POLB P06746 3/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2521923 0.87 KDM4E (0.57) KDM4EALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL4090313 0.85 ALDH1A1 (0.42) KDM4EALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL21875225 0.85 RAB9A (0.49) KDM4EALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL29684910 0.84 AKR1C3 (0.49) KDM4EALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL16185374 0.84 MEN1 (0.47) KDM4EALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL24786179 0.84 KMT2A (0.51) KDM4EALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL25546783 0.84 KDM4E (0.42) KDM4EALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL23239603 0.84 AKR1C3 (0.49) KDM4EALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL14295749 0.84 AKR1C3 (0.49) KDM4EALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL18482068 0.84 MAPT (0.45) KDM4EALDH1A1MAPTHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10573819-B2 Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2020-02-25 US disclosed
US-10573819-B2 Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2020-02-25 US disclosed
US-20170288148-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2017-10-05 US disclosed
US-20170288148-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2017-10-05 US disclosed
US-9748492-B2 Organic electroluminescent device IDEMITSU KOSAN CO., LTD. (JP) 2017-08-29 US disclosed
US-20160211456-A1 PHENANTHRO[9,10-b]TETRAPHENYLENE DERIVATIVE AND USE THEREOF LUMINESCENCE TECHNOLOGY CORP. 2016-07-21 US disclosed
US-20160211456-A1 PHENANTHRO[9,10-b]TETRAPHENYLENE DERIVATIVE AND USE THEREOF LUMINESCENCE TECHNOLOGY CORP. 2016-07-21 US disclosed
US-20160211456-A1 PHENANTHRO[9,10-b]TETRAPHENYLENE DERIVATIVE AND USE THEREOF LUMINESCENCE TECHNOLOGY CORP. 2016-07-21 US disclosed
WO-2016036031-A1 COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME SK CHEMICALS CO., LTD. (KR) 2016-03-10 WO disclosed
WO-2016036031-A1 COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME SK CHEMICALS CO., LTD. (KR) 2016-03-10 WO disclosed
US-20140131681-A1 ORGANIC ELECTROLUMINESCENT DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2014-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10573819-B2 Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof OCIAD1, GPX1, PIEZO1 KDM4E 928/4885ALDH1A1 453/4885MAPT 2496/4885
US-20170288148-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF OCIAD1, GPX1, PIEZO1 KDM4E 928/4885ALDH1A1 453/4885MAPT 2496/4885
US-20160211456-A1 PHENANTHRO[9,10-b]TETRAPHENYLENE DERIVATIVE AND USE THEREOF POP1, TERB1, AP2B1 KDM4E 2546/4885ALDH1A1 2052/4885MAPT 1660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.